Core Viewpoint - Ming Chi Hospital (2581.HK) experienced a significant drop on its first day of trading, falling over 43% to HKD 5.28, resulting in a market capitalization of HKD 1.64 billion, despite an IPO pricing of HKD 9.34 and a public offering subscription rate of 6.28 times [1] Financial Performance - The company's revenue increased from HKD 2,336.4 million in 2022 to HKD 2,687.6 million in 2023, with a slight decrease projected to HKD 2,659.0 million in 2024 [1] - The gross profit margin improved from 16.4% in 2022 to 18.9% in 2023, with a forecasted decline to 18.1% in 2024 [1] - Net profit for the years 2022, 2023, and 2024 was reported at HKD 89.6 million, HKD 167.5 million, and HKD 108.9 million respectively, with net profit margins of 3.8%, 6.2%, and 4.1% for the same years [1]
港股异动丨首日上市破发，明基医院暴跌43%